Quarterly report · Q3

Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥76.8bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥98.0bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥73.6bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥14.3bn2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥14.4bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥13.9bn2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥18.1bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥14.6bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥13.9bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥14.6bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥10.3bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥11.8bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥10.4bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥10.3bn2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥10.5bn2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥190.1bnat 2022-12-31Cons.Assets
Total assets¥189.3bnat 2022-03-31Cons.Assets
Total assets¥185.5bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥98.8bnat 2022-12-31Cons.Liabilities
Total liabilities¥103.8bnat 2022-03-31Cons.Liabilities
Net assets / equity¥91.3bnat 2022-12-31Cons.Net assets
Net assets / equity¥85.5bnat 2022-03-31Cons.Net assets
Net assets / equity¥83.9bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥51.1bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥51.6bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥184.092022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥50.672022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥209.132021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥183.32021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥64.432021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio48.0%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio45.2%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio45.0%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-12-31¥2.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-12-31¥2.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-12-31¥217m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31¥1m
jpcrp040300-q3r_E00913-000Electronics Materialsreportable segmentrevenue2022-04-01 → 2022-12-31¥55.3bn
jpcrp040300-q3r_E00913-000Electronics Materialsreportable segmentrevenue external2022-04-01 → 2022-12-31¥55.3bn
jpcrp040300-q3r_E00913-000Electronics Materialsreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥0
jpcrp040300-q3r_E00913-000Electronics Materialsreportable segmentsegment profit2022-04-01 → 2022-12-31¥14.2bn
jpcrp040300-q3r_E00913-000Medical And Pharmaceuticalreportable segmentrevenue2022-04-01 → 2022-12-31¥18.9bn
jpcrp040300-q3r_E00913-000Medical And Pharmaceuticalreportable segmentrevenue external2022-04-01 → 2022-12-31¥18.9bn
jpcrp040300-q3r_E00913-000Medical And Pharmaceuticalreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.4bn
—segment totalrevenue2022-04-01 → 2022-12-31¥74.2bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥74.2bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥0
—segment totalsegment profit2022-04-01 → 2022-12-31¥15.5bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥77.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥76.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥217m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥15.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-12-31¥2.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-12-31¥2.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-12-31¥90m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-12-31−¥4m
jpcrp040300-q3r_E00913-000Electronics Materialsreportable segmentrevenue2021-04-01 → 2021-12-31¥53.0bn
jpcrp040300-q3r_E00913-000Electronics Materialsreportable segmentrevenue external2021-04-01 → 2021-12-31¥53.0bn
jpcrp040300-q3r_E00913-000Electronics Materialsreportable segmentsegment profit2021-04-01 → 2021-12-31¥12.6bn
jpcrp040300-q3r_E00913-000Medical And Pharmaceuticalreportable segmentrevenue2021-04-01 → 2021-12-31¥18.1bn
jpcrp040300-q3r_E00913-000Medical And Pharmaceuticalreportable segmentrevenue external2021-04-01 → 2021-12-31¥18.1bn
jpcrp040300-q3r_E00913-000Medical And Pharmaceuticalreportable segmentsegment profit2021-04-01 → 2021-12-31¥2.5bn
—segment totalrevenue2021-04-01 → 2021-12-31¥71.1bn
—segment totalrevenue external2021-04-01 → 2021-12-31¥71.1bn
—segment totalsegment profit2021-04-01 → 2021-12-31¥15.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥73.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥73.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-12-31¥90m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥15.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 349
ItemContextValueUnit
Liabilities and net assetsCurrentQuarterInstant190135000000JPY
Net salesPrior1YTDDuration73622000000JPY
Net salesCurrentYTDDuration76772000000JPY
Cost of salesPrior1YTDDuration41030000000JPY
Cost of salesCurrentYTDDuration42170000000JPY
Gross profitPrior1YTDDuration32592000000JPY
Gross profitCurrentYTDDuration34602000000JPY
Selling general and administrative expensesPrior1YTDDuration18221000000JPY
Selling general and administrative expensesCurrentYTDDuration20332000000JPY
Operating incomePrior1YTDDuration14370000000JPY
Operating incomeCurrentYTDDuration14269000000JPY
Interest income noiPrior1YTDDuration38000000JPY
Interest income noiCurrentYTDDuration68000000JPY
Dividends income noiPrior1YTDDuration24000000JPY
Dividends income noiCurrentYTDDuration29000000JPY
Subsidy income noiPrior1YTDDuration127000000JPY
Subsidy income noiCurrentYTDDuration64000000JPY
Compensation income noiPrior1YTDDuration286000000JPY
Compensation income noiCurrentYTDDuration-JPY
Fiduciary obligation fee noiPrior1YTDDuration66000000JPY
Fiduciary obligation fee noiCurrentYTDDuration63000000JPY
Other noiPrior1YTDDuration126000000JPY
Other noiCurrentYTDDuration150000000JPY
Non operating incomePrior1YTDDuration670000000JPY
Non operating incomeCurrentYTDDuration377000000JPY
Interest expenses noePrior1YTDDuration195000000JPY
Interest expenses noeCurrentYTDDuration345000000JPY
Foreign exchange losses noePrior1YTDDuration58000000JPY
Foreign exchange losses noeCurrentYTDDuration262000000JPY
Other noePrior1YTDDuration150000000JPY
Other noeCurrentYTDDuration127000000JPY
Non operating expensesPrior1YTDDuration403000000JPY
Non operating expensesCurrentYTDDuration735000000JPY
Ordinary incomePrior1YTDDuration14637000000JPY
Ordinary incomeCurrentYTDDuration13910000000JPY
Income before income taxesPrior1YTDDuration14637000000JPY
Income before income taxesCurrentYTDDuration13910000000JPY
Income taxes currentPrior1YTDDuration3572000000JPY
Income taxes currentCurrentYTDDuration3378000000JPY
Income taxes deferredPrior1YTDDuration553000000JPY
Income taxes deferredCurrentYTDDuration213000000JPY
Income taxesPrior1YTDDuration4125000000JPY
Income taxesCurrentYTDDuration3591000000JPY
Profit lossPrior1YTDDuration10511000000JPY
Profit lossCurrentYTDDuration10319000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration151000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration-0JPY
Profit loss attributable to owners of parentPrior1YTDDuration10360000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration10320000000JPY
Profit lossPrior1YTDDuration10511000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass